Birmingham, AL, October 19, 2026 —

John McMillan, director of the Alabama Medical Cannabis Commission, is set to retire on October 29, concluding a tenure that coincided with significant delays and controversies in the rollout of Alabama’s medical cannabis program.

The information provided does not specify the year of McMillan’s retirement date or when his departure was announced. It also does not identify a successor or say whether the commission has outlined plans for leadership after he leaves.

The summary describes delays and controversies surrounding the program’s rollout but does not detail the issues involved, their causes or their effects. It does not provide a timeline for the rollout, describe the commission’s actions, or indicate the program’s current status. No statements from McMillan or the commission were included.

McMillan’s retirement marks a leadership change at the state commission responsible for Alabama’s medical cannabis program. The available information does not establish whether the departure will affect the program’s operations or schedule. Further details about the transition, the issues during McMillan’s tenure and the commission’s next steps were not provided.


Story summarized from the original created by Jonathan Hardison on www.wbrc.com, see more information here.

Media gallery

About The Author